Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian A Forrest

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
American Journal of Physiology. Lung Cellular and Molecular Physiology|January 22, 2008
Simvastatin attenuates release of neutrophilic and remodeling factors from primary bronchial epithelial cells derived from stable lung transplant recipientsDesmond M Murphy, Ian A Forrest, Paul A Corris, et al.
The European Respiratory Journal|November 20, 2020
Target inhibition of galectin-3 by inhaled TD139 in patients with idiopathic pulmonary fibrosisNikhil Hirani, Alison C MacKinnon, Lisa Nicol, et al.
The Lancet. Respiratory Medicine|September 8, 2022
Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 studyJoshua J Solomon, Sonye K Danoff, Felix A Woodhead, et al.
American Journal of Respiratory and Critical Care Medicine|October 2, 2020
Outcome of Hospitalization for COVID-19 in Patients with Interstitial Lung Disease. An International Multicenter StudyThomas M Drake, Annemarie B Docherty, Ewen M Harrison, et al.
ERJ Open Research|January 16, 2024
Real-world experience of nintedanib for progressive fibrosing interstitial lung disease in the UKGiles Dixon, Samuel Hague, Sarah Mulholland, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
American Journal of Physiology. Lung Cellular and Molecular Physiology|January 22, 2008
Simvastatin attenuates release of neutrophilic and remodeling factors from primary bronchial epithelial cells derived from stable lung transplant recipientsDesmond M Murphy, Ian A Forrest, Paul A Corris, et al.
The European Respiratory Journal|November 20, 2020
Target inhibition of galectin-3 by inhaled TD139 in patients with idiopathic pulmonary fibrosisNikhil Hirani, Alison C MacKinnon, Lisa Nicol, et al.
The Lancet. Respiratory Medicine|September 8, 2022
Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 studyJoshua J Solomon, Sonye K Danoff, Felix A Woodhead, et al.
American Journal of Respiratory and Critical Care Medicine|October 2, 2020
Outcome of Hospitalization for COVID-19 in Patients with Interstitial Lung Disease. An International Multicenter StudyThomas M Drake, Annemarie B Docherty, Ewen M Harrison, et al.
ERJ Open Research|January 16, 2024
Real-world experience of nintedanib for progressive fibrosing interstitial lung disease in the UKGiles Dixon, Samuel Hague, Sarah Mulholland, et al.
Pageof 2